﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropharmacology</JournalTitle>
      <Issn>2345-4202</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2017</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Impact of Kelussia odoratissima Mozaffarian lipid profile and fasting blood sugar in hyperlipidemia patients</ArticleTitle>
    <FirstPage>9</FirstPage>
    <LastPage>12</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Marzieh</FirstName>
        <LastName>Kafeshani</LastName>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Mirhosseini</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Momeni</LastName>
      </Author>
      <Author>
        <FirstName>Rahmatollah</FirstName>
        <LastName>Rabiei</LastName>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Rafieian-Kopaei</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Introduction: Hyperlipidemia is associated with increased risk of cardiovascular disease. Each type of medication works differently and has different types of side effects. Flavonoids are a group of polyphenolic compounds with antioxidant properties that help reducing the cardiovascular risk factors. Kelussia odoratissima is a flavonoid containing plant. Objectives: The aim of this study was investigating the effect of this herb on lipid and glucose profile in hyperlipidemia patients.Patients and Methods: This study performed on 61 hyperlipidemia patients. They assigned in control and intervention groups. The control group received 40 mg/day of lovastatin and intervention group received 40 mg/day of Lovastatin plus 2 g/day powder of Kelussia odoratissima. Before, two weeks and 1 month after the beginning of the study, cholesterol, triglyceride (TG), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), high density lipoprotein cholesterol (HDL-C), and fasting blood sugar (FBS) were measured. Data were analyzed by variance analysis with repeated measures, chi-square and t tests. Results: The reduction rate of cholesterol, TG, VLDL-C and LDL-C was similar in the control and intervention groups. The HDL-C rate was higher in intervention group compared to control group (P &lt; 0.05). The mean LDL/HDL ratio decreased during the study (P &lt; 0.001); however, there was not any significant difference between the two groups (P &gt; 0.05). The mean of FBS did not change between and within groups (P &gt; 0.05). Conclusion: Kelussia odoratissima did not have a desirable effect on serum lipid profile and FBS in hyperlipidemic patients that use lovastatin, but is able to increase HDL-C significantly</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Hyperlipidemia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Human</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Kelussia odoratissima</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Triglyceride</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cholesterol</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>